These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6729909)

  • 21. Induction chemotherapy followed by alternating chemo-radiotherapy in non-endemic undifferentiated carcinoma of the nasopharynx: optimal compliance and promising 4-year results.
    Ponzanelli A; Vigo V; Marcenaro M; Bacigalupo A; Gatteschi B; Ravetti JL; Corvò R; Benasso M
    Oral Oncol; 2008 Aug; 44(8):767-74. PubMed ID: 18061519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [60Co teletherapy plus afterloading intracavitary radiation in nasopharyngeal carcinoma--report on 22 patients].
    Zhang YW
    Zhonghua Zhong Liu Za Zhi; 1985 Jan; 7(1):52-4. PubMed ID: 3979253
    [No Abstract]   [Full Text] [Related]  

  • 23. Ten-year experience with linear accelerator irradiation of cancer of the nasopharynx.
    Thompson RW; Doggett RL; Bagshaw MA
    Radiology; 1970 Oct; 97(1):149-55. PubMed ID: 5459348
    [No Abstract]   [Full Text] [Related]  

  • 24. Prognostic factors of poorly-differentiated squamous cell carcinoma of the nasopharynx.
    Mitsuhashi N; Niibe H; Hayakawa K; Tamaki Y; Takahashi M; Yamakawa M; Hashida I; Akimoto T; Kiryu Y
    Jpn J Clin Oncol; 1994 Aug; 24(4):191-8. PubMed ID: 8072197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Our experience with the treatment of nasopharyngeal tumors.
    Boljesíková E; Durkovský J; Michalíková B
    Neoplasma; 1982; 29(3):351-7. PubMed ID: 6752734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience in fractionated stereotactic body radiation therapy boost for newly diagnosed nasopharyngeal carcinoma.
    Chen HH; Tsai ST; Wang MS; Wu YH; Hsueh WT; Yang MW; Yeh IC; Lin JC
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1408-14. PubMed ID: 17126207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reirradiation for locally recurrent nasopharyngeal carcinoma: treatment results and prognostic factors.
    Oksüz DC; Meral G; Uzel O; Cağatay P; Turkan S
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):388-94. PubMed ID: 15380570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer of the pharynx. A study based on 2,417 cases with special reference to radiation treatment.
    Lederman M
    J Laryngol Otol; 1967 Feb; 81(2):151-72. PubMed ID: 6017211
    [No Abstract]   [Full Text] [Related]  

  • 29. Late complications of radiotherapy for nasopharyngeal carcinoma.
    Sumitsawan Y; Chaiyasate S; Chitapanarux I; Anansuthiwara M; Roongrotwattanasiri K; Vaseenon V; Tooncam H
    Auris Nasus Larynx; 2009 Apr; 36(2):205-9. PubMed ID: 18635325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective study of p53 expression and its correlation with clinical response of radiotherapy in nasopharyngeal carcinoma.
    Ho KY; Kuo WR; Chai CY; Tsai SM; Sheu SH; Wu SC; Juan KH
    Laryngoscope; 2001 Jan; 111(1):131-6. PubMed ID: 11192881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Carcinomas of the Nasopharynx. Clinical aspects--treatment results--therapeutical improvements (author's transl)].
    Leipner N; Barwig P; Frommhold H
    Laryngol Rhinol Otol (Stuttg); 1981 Jun; 60(6):321-8. PubMed ID: 7266199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment results in nasopharyngeal cancer following cobalt teletherapy].
    Ziegler F; Metzger H; Hübener KH
    Strahlentherapie Sonderb; 1984; 78():90-2. PubMed ID: 6729914
    [No Abstract]   [Full Text] [Related]  

  • 33. Association between high initial tissue levels of cyclin d1 and recurrence of nasopharyngeal carcinoma.
    Lai JP; Tong CL; Hong C; Xiao JY; Tao ZD; Zhang Z; Tong WM; Betz CS
    Laryngoscope; 2002 Feb; 112(2):402-8. PubMed ID: 11889405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of radiotherapeutic treatment of cancer of the mouth floor].
    Schertel L; Mohring R; Brümmer G
    Rontgenpraxis; 1991 Mar; 44(3):89-95. PubMed ID: 2035118
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase II study: concurrent chemo-radiotherapy in advanced nasopharyngeal carcinoma.
    Maoleekoonpairoj S; Phromratanapongse P; Puttanuparp S
    J Med Assoc Thai; 1997 Dec; 80(12):778-84. PubMed ID: 9470331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A new applicator with regulatable air bag designed for intracavitary brachytherapy of nasopharyngeal carcinoma].
    Zhang N; Wei GY; Tan YC; Huang ZL; Li SE; Lu ZQ
    Ai Zheng; 2004 Oct; 23(10):1222-4. PubMed ID: 15473941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of Tanderil in radiotherapy].
    Roussel JM; Schoumacher P; Pernot M; Manivit P
    J Radiol Electrol Med Nucl; 1968; 49(1):140-7. PubMed ID: 5662096
    [No Abstract]   [Full Text] [Related]  

  • 38. Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma.
    Kwong DL; Wei WI; Cheng AC; Choy DT; Lo AT; Wu PM; Sham JS
    Cancer; 2001 Mar; 91(6):1105-13. PubMed ID: 11267955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Radiation-induced cancer of the cavum (35 years later after curietherapy of nasopharyngeal fibroma)].
    Pech A; Lisbonis JM; Hermanovitch M; Iberto-Mazzali A; Tiziano JP
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1970 Nov; 19(9):743-4. PubMed ID: 4250350
    [No Abstract]   [Full Text] [Related]  

  • 40. Determination of nonendemic nasopharyngeal carcinoma by in situ hybridization for Epstein-Barr virus EBER1 RNA: sensitivity and specificity in cervical node metastases.
    Dictor M; Sivén M; Tennvall J; Rambech E
    Laryngoscope; 1995 Apr; 105(4 Pt 1):407-12. PubMed ID: 7536285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.